Skip to main content
. 2023 Jul 19;11:1192099. doi: 10.3389/fpubh.2023.1192099

Figure 1.

Figure 1

Flowchart UK Biobank Omega-3 users - B18, Chronic viral hepatitis; B20, Human immunodeficiency virus disease resulting in infectious and parasitic disease; B21, Human immunodeficiency virus disease resulting in malignant neoplasms; B22, Human immunodeficiency virus disease resulting in other specified diseases; B23, Human immunodeficiency virus disease resulting in other conditions; B24, Unspecified human immunodeficiency virus disease; C22.0, Hepatocellular carcinoma; K70, Alcoholic liver disease; K71, Toxic liver disease; K72, Hepatic failure, not elsewhere classified; K73, Chronic hepatitis, not elsewhere classified; K74, Fibrosis and cirrhosis of liver; K75, Other inflammatory liver diseases; K76, Other diseases of liver; K77, Liver disorders in diseases classified elsewhere. *Missing values were excluded from the cox proportional hazards model. This was the case for physical activity, diet, alcohol consumption and socioeconomic status.